Literature DB >> 26121339

Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121339      PMCID: PMC4488309          DOI: 10.1371/journal.pone.0132230

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.

Notice of Republication

This article was republished on June 15, 2015, to correct an error in the title. The publisher apologizes for the error. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Originally published, uncorrected article.

(PDF) Click here for additional data file.

Republished, corrected article.

(PDF) Click here for additional data file.
  1 in total

1.  Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.

Authors:  Joost C M Uitdehaag; Jeroen A D M de Roos; Antoon M van Doornmalen; Martine B W Prinsen; Jill A P Spijkers-Hagelstein; Judith R F de Vetter; Jos de Man; Rogier C Buijsman; Guido J R Zaman
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.